Stocks near 52 week low

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × The ongoing downturn in the domestic stock market has seen nearly 83 percent of the stocks forming the Nifty 500 index, a collection of the biggest companies in the country, deliver flat or negative returns in 2022 so far. Many of these stocks are hovering below their 52-week lows and their 200-day moving average (DMA), data compiled by Moneycontrol showed. So far this year, the Nifty 500 index lost 12 percent, while the BSE Sensex and Nifty 50 have declined nearly 10 percent each. Companies that have seen the most erosion in their stock prices since the start of this year include Dhani Services , Solara Active Pharma , Brightcom Group , Indiabulls Real Estate , Metropolis Healthcare , Hikal , Indiabulls Housing Finance , Dilip Buildcon , Welspun India , Nazara Tech , … [Read more...] about Bear Market Woes: 83% of Nifty 500 stocks give negative returns in 2022

Shares of the digital transaction giants have plummeted in reaction to fallout from the coronavirus pandemic, which will sharply lower volumes in the first and second quarters. Two elite members of this group have held long-term uptrends and reached deep support levels , while the third has already entered bear market territory. The prognosis looks poor for the entire group, but a little good news could go a long way in alleviating the deteriorating outlooks. These companies depend on healthy consumer and business spending because they make their money by taking a little bite out of each transaction. In turn, that makes them highly vulnerable to periods of economic stress and contraction when everyone is hoarding capital to save for tough times. While the boom in card-less processing has eased some of this burden, it won't save these issues from a recession or depression. Visa Inc. ( V ) stock has been engaged in a powerful uptrend since bottoming out near $10 in March … [Read more...] about Digital Payment Stocks Could Enter Bear Markets

Wall Street's main indexes rose over 1% on Friday as signs of slowing economic growth and falling commodity prices tempered expectations over how high the Federal Reserve will raise interest rates to rein in inflation. Global financial markets have been roiled this month on worries that rapid rate hikes by major central banks could cause a recession, with the benchmark S&P 500 (.SPX) confirming a bear market last week as it recorded a 20% drop from its January closing peak. The three main indexes on Friday looked set to notch their first weekly gain in four, boosted by megacap growth stocks and defensive sectors such as healthcare and utilities seen as safer bets during times of economic uncertainty. "Conversations about the U.S. economy likely slowing which could lessen the hawkishness of the Fed, combined with lower commodity prices and bond yields - these are reasons investors are mentioning to justify why we could experience a near-term bounce," said Sam Stovall, … [Read more...] about Wall Street rallies as traders dial back rate-hike bets

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × Sharekhan's research report on Dr. Reddy’s Laboratories In its investor’s day, DRL has unveiled its two-pronged growth strategy across its business which could propel the growth. In the short to medium term DRL intends to focus on existing business/products lines while over the long-term new areas such as differentiated formulations, CDMO and Biologics would be the focus area. Basis the growth strategy unveiled DRL has guided for a double digit revenue growth and EBITDA margins at 25% over the medium term. Near-term challenges in the form of elevated cost pressures, demand volatility, price erosion and geo-political issues could affect the performance, though DRL’s long-term growth levers are intact. Outlook We retain our Buy recommendation on the stock with an unchanged PT of … [Read more...] about Buy Dr. Reddy’s Laboratories; target of Rs 5550: Sharekhan

Trade Watchlist Portfolio Message Set Alert live bse live nse live Volume Todays L/H More × Sharekhan's research report on Amber Enterprises Amber Enterprises Limited (Amber) expects Q1 and FY2023 to be healthy as industry growth is expected at over 30% y-o-y and the company aims to gain 100 bps in market share. Long-term growth will be driven by sectoral tailwinds such as increasing affordability, rising temperature, PLI scheme benefits, and reducing dependency on imports in the air conditioner industry. Amber would strengthen its market share in the long term through backward integration, which would enhance its product offerings, entry into new categories, and focus on growing exports to combat the sector’s seasonality. Outlook The stock has corrected sharply by ~35% in the recent past; we believe near-term margin pressure and global headwinds are largely factored in … [Read more...] about Buy Amber Enterprises; target of Rs 3075: Sharekhan

CVS Health Corporation ( CVS ) shares fell more than 1.2% on Thursday, breaking down from key channel support levels . Since the health services company reported fourth quarter financial results on Feb. 19, the stock has plunged nearly 24% to fresh 52-week lows. Investors remain concerned about the stability of the company's existing businesses, as well as the integration of Aetna following the acquisition. Earlier this week, Citi analysts lowered their price target on CVS shares from $94.00 to $68.00, but they maintained a Buy rating. The analyst says that retail headwinds are significant, but he's most surprised by the significant drop in the health care benefits segment. He admits that it's difficult to gain visibility into 2020 but sees a "reasonable path" to $7.20 in earnings per share next year, justifying his current rating. These sentiments mirrored those of other analysts that weighed in earlier. While analysts have downgraded CVS stock due to the uncertainty, … [Read more...] about CVS Breaks Down From Channel Support as Freefall Continues

- A + A NEW YORK/BENGALURU (June 24): Wall Street's main indexes climbed more than 2% on Friday, as signs of slowing economic growth and a recent weakening of commodity prices tempered expectations over how high the Federal Reserve will raise interest rates to rein in inflation. Global financial markets have been roiled this month on worries that rapid rate hikes by major central banks could cause a recession, with the benchmark S&P 500 confirming a bear market last week as it recorded a 20% drop from its January closing peak. The three main indexes looked set to notch their first weekly gain of the month, boosted by megacap growth stocks and defensive sectors such as healthcare and utilities seen as safer bets during times of economic uncertainty. "The reality is there's some optimism that the weakening economy, the stronger potential for a recession down the road could actually impede the Fed's aggressive hiking schedule," said Ryan Detrick, chief market … [Read more...] about Wall St rallies as traders dial back rate-hike bets

One of them, Rob Walton, just led a family group to bid $4.65 billion for the Denver Broncos NFL team. Here are the other heirs that rank the highest on Forbes’ list. A shock ran through the sporting world last week when a group led by Walmart heir Rob Walton won the bidding war for the Denver Broncos NFL team with a $4.65 billion offer . The eye-popping sum made the deal the most expensive sports team purchase in history and turned a spotlight on the man at the center of it all: the typically low-profile Walton. The eldest son of Walmart founder Sam Walton, he inherited his fortune and served as Walmart’s chairman for 23 years. Now worth $57.2 billion, he is the 15th richest person in America and the fifth richest U.S. heir. A handful of Rob Walton’s relatives are among America’s richest people as well. Founded in 1962 by Sam and his brother James “Bud” Walton, Walmart, the country’s largest retailer, is still about half owned by members of the family. Seven have … [Read more...] about They Inherited Billions Upon Billions: Meet America’s Richest Heirs